To further assess the impact of APOE induction on the efficacy of immunotherapy, RM-1 cells were utilized to establish a xenograft tumor model to evaluate the response to anti-PD-L1 treatment under conditions of APOE induction, induced either by RGX104 treatment or Apoe overexpression (Figure 8C). The gene discussed is APOE; the disease is neoplasm.